ScripsAmerica Updates Status of 10K Filing Comp
Post# of 7769
Posted On: 04/15/2015 6:06:07 PM
ScripsAmerica Updates Status of 10K Filing
Company Release - 04/15/2015 17:30
TYSONS CORNER, Va., April 15, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today announced that it will be unable to file its 2014 Annual Report on Form 10-K with the Securities and Exchange Commission by the extension deadline of April 15, 2015.
Due to the explosive growth in revenues, which rose to $30 million in 2014 from just $600,000 in 2013, the vast majority of which was generated over the last two quarters of 2014, our auditors have required additional time to perform the thorough analysis incumbent in an Audit. We are confident that our results of operations and financial position have been properly reflected in the preliminary results we have issued for both fiscal 2014 as well as the first quarter of fiscal 2015 as most recently disclosed in our April 13, 2015 presentation at the Growth Capital Expo. That presentation is available on our website at
http://www.snl.com/IRW/Presentations/4578348.
Mr. Robert Schneiderman, Chief Executive Officer and Co-Founder, said, "The auditor's work on the 10-K filing has not interfered with our operations or our ability to execute our growth strategy. ScripsAmerica is fundamentally sound and is looking forward to a record 2015."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
CONTACT: Joe Hassett
Gregory FCA
610-228-2110
joeh@gregoryfca.com
Company Release - 04/15/2015 17:30
TYSONS CORNER, Va., April 15, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today announced that it will be unable to file its 2014 Annual Report on Form 10-K with the Securities and Exchange Commission by the extension deadline of April 15, 2015.
Due to the explosive growth in revenues, which rose to $30 million in 2014 from just $600,000 in 2013, the vast majority of which was generated over the last two quarters of 2014, our auditors have required additional time to perform the thorough analysis incumbent in an Audit. We are confident that our results of operations and financial position have been properly reflected in the preliminary results we have issued for both fiscal 2014 as well as the first quarter of fiscal 2015 as most recently disclosed in our April 13, 2015 presentation at the Growth Capital Expo. That presentation is available on our website at
http://www.snl.com/IRW/Presentations/4578348.
Mr. Robert Schneiderman, Chief Executive Officer and Co-Founder, said, "The auditor's work on the 10-K filing has not interfered with our operations or our ability to execute our growth strategy. ScripsAmerica is fundamentally sound and is looking forward to a record 2015."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
CONTACT: Joe Hassett
Gregory FCA
610-228-2110
joeh@gregoryfca.com
(0)
(0)